Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OP1L
|
|||
| Drug Name |
Anti-CEA CAR-T therapy
|
|||
| Indication | Liver metastasis [ICD-11: 2D80; ICD-10: C78.7] | Phase 1 | [1] | |
| Metastatic liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 1 | [2] | ||
| Company |
Sorrento Therapeutics San Diego, CATNK TherapeuticsSan Diego, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.